SCHEMBL6550957

SCHEMBL6550957

O=C(O)c1sccc1SCc1ccc(Cl)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 1.00
PTPRG P23470 6/20 0.67
PTPRC P08575 6/20 0.66
MAPT P10636 1/20 0.62
ALDH1A1 P00352 2/20 0.45
GAA P10253 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
MBOAT4 Q96T53 1/20 0.45
IDO1 P14902 1/20 0.44
AR P10275 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
POLB P06746 1/20 0.43
EPHX1 P07099 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6550959 0.81 KMT2A (0.67) KMT2APTPRGPTPRCMAPTALDH1A1
SCHEMBL7830138 0.80 PTPRG (1.00) KMT2APTPRGPTPRCMAPTALDH1A1
SCHEMBL7509205 0.77 PTPRG (1.00) KMT2APTPRGPTPRCMAPT
SCHEMBL7823399 0.76 PTPRC (0.75) KMT2APTPRGPTPRCMAPT
SCHEMBL18171985 0.73 KMT2A (0.64) KMT2APTPRGPTPRCMAPTALDH1A1
SCHEMBL4019876 0.71 PTPRG (0.67) KMT2APTPRGPTPRCMAPTALDH1A1
SCHEMBL953378 0.69 KMT2A (0.52) KMT2APTPRGPTPRCALDH1A1CYP3A4
SCHEMBL4021401 0.69 PTPRC (0.75) KMT2APTPRGPTPRCMAPTALDH1A1
SCHEMBL31568471 0.68 MRGPRX4 (0.63) KMT2APTPRGMAPTALDH1A1GAA
SCHEMBL30396557 0.68 KMT2A (0.51) KMT2AALDH1A1GAAMAPK1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1638766-A Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase AVENTIS PHARMA GMBH (DE) 2005-07-13 CN disclosed
EP-1482929-A1 USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE Aventis Pharma Deutschland GmbH (DE) 2004-12-08 EP disclosed
WO-2003072098-A1 USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-04 WO disclosed
EP-1263745-A1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE Aventis Pharma Deutschland GmbH (DE) 2002-12-11 EP disclosed
WO-2001066531-A1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-09-13 WO disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed